123 related articles for article (PubMed ID: 10588765)
1. Impairment of natural killer cell activity in Chlamydia trachomatis infected individuals.
Mavoungou E; Poaty-Mavoungou V; Touré FS; Sall A; Delicat A; Yaba P; Mandeme Y; Nabias R; Lansoud-Soukate J
Trop Med Int Health; 1999 Nov; 4(11):719-27. PubMed ID: 10588765
[TBL] [Abstract][Full Text] [Related]
2. Natural killer (NK) cell activity during HIV infection: a decrease in NK activity is observed at the clonal level and is not restored after in vitro long-term culture of NK cells.
Scott-Algara D; Vuillier F; Cayota A; Dighiero G
Clin Exp Immunol; 1992 Nov; 90(2):181-7. PubMed ID: 1424272
[TBL] [Abstract][Full Text] [Related]
3. Effects of Chlamydia trachomatis infection on the expression of natural killer (NK) cell ligands and susceptibility to NK cell lysis.
Hook CE; Telyatnikova N; Goodall JC; Braud VM; Carmichael AJ; Wills MR; Gaston JS
Clin Exp Immunol; 2004 Oct; 138(1):54-60. PubMed ID: 15373905
[TBL] [Abstract][Full Text] [Related]
4. Humoral and cellular immunity in secondary infection due to murine Chlamydia trachomatis.
Williams DM; Grubbs BG; Pack E; Kelly K; Rank RG
Infect Immun; 1997 Jul; 65(7):2876-82. PubMed ID: 9199462
[TBL] [Abstract][Full Text] [Related]
5. Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon-γ or interleukin-10 are expanded in asymptomatic, E antigen-negative patients with persistent hepatitis B virus infection.
Conroy MJ; Mac Nicholas R; Grealy R; Taylor M; Otegbayo JA; O'Dea S; Mulcahy F; Ryan T; Norris S; Doherty DG
J Viral Hepat; 2015 Mar; 22(3):335-45. PubMed ID: 25186004
[TBL] [Abstract][Full Text] [Related]
6. Infection of epithelial and dendritic cells by Chlamydia trachomatis results in IL-18 and IL-12 production, leading to interferon-gamma production by human natural killer cells.
Hook CE; Matyszak MK; Gaston JS
FEMS Immunol Med Microbiol; 2005 Aug; 45(2):113-20. PubMed ID: 16051062
[TBL] [Abstract][Full Text] [Related]
7. The Predominant CD4
Jordan SJ; Gupta K; Ogendi BMO; Bakshi RK; Kapil R; Press CG; Sabbaj S; Lee JY; Geisler WM
Clin Vaccine Immunol; 2017 Apr; 24(4):. PubMed ID: 28100498
[No Abstract] [Full Text] [Related]
8. Role of NK cells in early host response to chlamydial genital infection.
Tseng CT; Rank RG
Infect Immun; 1998 Dec; 66(12):5867-75. PubMed ID: 9826367
[TBL] [Abstract][Full Text] [Related]
9. Effects of interleukin-12 on natural killer cell cytotoxicity and the production of interferon-gamma and tumour necrosis factor-alpha in patients with myelodysplastic syndromes.
Ogata K; Tamura H; Yokose N; An E; Dan K; Hamaguchi H; Sakamaki H; Onozawa Y; Clark SC; Nomura T
Br J Haematol; 1995 May; 90(1):15-21. PubMed ID: 7786778
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of human NK cell-associated gene expression following activation by IL-2, IFN-alpha and PMA/ionomycin.
Mori S; Jewett A; Cavalcanti M; Murakami-Mori K; Nakamura S; Bonavida B
Int J Oncol; 1998 May; 12(5):1165-70. PubMed ID: 9538144
[TBL] [Abstract][Full Text] [Related]
11. An Adaptive
Bakshi RK; Gupta K; Jordan SJ; Chi X; Lensing SY; Press CG; Geisler WM
Front Immunol; 2018; 9():1981. PubMed ID: 30245688
[No Abstract] [Full Text] [Related]
12. Production of tumor necrosis factor-alpha and interferon-gamma from human peripheral blood lymphocytes by MGN-3, a modified arabinoxylan from rice bran, and its synergy with interleukin-2 in vitro.
Ghoneum M; Jewett A
Cancer Detect Prev; 2000; 24(4):314-24. PubMed ID: 11059563
[TBL] [Abstract][Full Text] [Related]
13. Release of natural killer cytotoxic factor in patients with lymphoproliferative disease of granular lymphocytes.
Zambello R; Trentin L; Agostini C; Chisesi T; Vespignani M; Pizzolo G; Pandolfi F; Ensoli F; Semenzato G
Leuk Res; 1989; 13(4):315-22. PubMed ID: 2497276
[TBL] [Abstract][Full Text] [Related]
14. Induction of interferon-gamma from natural killer cells by immunostimulatory CpG DNA is mediated through plasmacytoid-dendritic-cell-produced interferon-alpha and tumour necrosis factor-alpha.
Marshall JD; Heeke DS; Abbate C; Yee P; Van Nest G
Immunology; 2006 Jan; 117(1):38-46. PubMed ID: 16423039
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of chlamydia trachomatis growth by human interferon-alpha: mechanisms and synergistic effect with interferon-gamma and tumor necrosis factor-alpha.
Ishihara T; Aga M; Hino K; Ushio C; Taniguchi M; Iwaki K; Ikeda M; Kurimoto M
Biomed Res; 2005 Aug; 26(4):179-85. PubMed ID: 16152734
[TBL] [Abstract][Full Text] [Related]
16. Induction of cytokines and cytotoxicity against tumor cells by Newcastle disease virus.
Zorn U; Dallmann I; Grosse J; Kirchner H; Poliwoda H; Atzpodien J
Cancer Biother; 1994; 9(3):225-35. PubMed ID: 7820184
[TBL] [Abstract][Full Text] [Related]
17. Cytokine gene polymorphism and Chlamydia trachomatis-specific immune responses.
Ohman H; Tiitinen A; Halttunen M; Paavonen J; Surcel HM
Hum Immunol; 2011 Mar; 72(3):278-82. PubMed ID: 21215285
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms accounting for the defective natural killer activity in patients with hairy cell leukemia.
Trentin L; Zambello R; Agostini C; Ambrosetti A; Chisesi T; Raimondi R; Bulian P; Pizzolo G; Semenzato G
Blood; 1990 Apr; 75(7):1525-30. PubMed ID: 2317560
[TBL] [Abstract][Full Text] [Related]
19. Identification of Chlamydia trachomatis Antigens Recognized by T Cells From Highly Exposed Women Who Limit or Resist Genital Tract Infection.
Russell AN; Zheng X; O'Connell CM; Wiesenfeld HC; Hillier SL; Taylor BD; Picard MD; Flechtner JB; Zhong W; Frazer LC; Darville T
J Infect Dis; 2016 Dec; 214(12):1884-1892. PubMed ID: 27738051
[TBL] [Abstract][Full Text] [Related]
20. Chlamydia pneumoniae and Chlamydia Trachomatis Infection Differentially Modulates Human Dendritic Cell Line (MUTZ) Differentiation and Activation.
Armitage CW; O'Meara CP; Beagley KW
Scand J Immunol; 2015 Jul; 82(1):48-54. PubMed ID: 25833314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
